Indo Us Biotech Shareholding Pattern
- Market cap
- ₹146 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹52.34 – ₹98.15
As of Jun 2026, promoters held 48.50% of Indo Us Biotech, foreign institutional investors 18.40%, domestic institutions 14.20% and the public 18.90%.
Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 9 October 2026. How this data is compiled.
Indo Us Biotech shareholding pattern — frequently asked questions
What is the promoter holding in Indo Us Biotech?
Promoters held 48.50% of Indo Us Biotech as of Jun 2026.
How much do FIIs hold in Indo Us Biotech?
Foreign institutional investors held 18.40% of Indo Us Biotech as of Jun 2026.
How much do domestic institutions hold in Indo Us Biotech?
Domestic institutional investors, including mutual funds and insurers, held 14.20% of Indo Us Biotech as of Jun 2026; mutual funds alone held 8.50%.
Who owns Indo Us Biotech?
As of Jun 2026, Indo Us Biotech's shareholders were promoters (48.50%), foreign institutional investors 18.40%, domestic institutions 14.20% and the public 18.90%, as filed with the stock exchanges.
Same Data For Peers
- Indraprastha Medical Corporation Limited shareholding pattern
- Indoco Remedies Limited shareholding pattern
- Ind-Swift Laboratories Limited shareholding pattern
- Indegene Limited shareholding pattern
- IOL Chemicals and Pharmaceuticals Limited shareholding pattern
- Healthcare Global Enterprises Limited shareholding pattern
Trade Indo Us Biotech With ATS
Track INDOUS live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.